Asthma Management Handbook
Close window

Table. Reviewing and adjusting preventer treatment for children aged 0–5 years

Initial treatment When to schedule review Management options and notes
Treatment response No treatment response †

Montelukast (children 2 years and over)

2–4 weeks

Continue montelukast treatment

 

Stop montelukast and start treatment with an inhaled corticosteroid, starting with a low dose

Inhaled corticosteroid (low dose)

4 weeks

Continue regular treatment at low dose

After ≥3 months, consider stopping treatment and reviewing in 4 weeks

Review the diagnosis, adherence and inhaler technique

Consider referral to a specialist (e.g. paediatric respiratory physician or paediatrician, if available) for assessment

Consider adding montelukast (in combination with inhaled corticosteroid)

  • Advise parents about potential adverse psychiatric effects of montelukast

† Symptom control not achieved with initial treatment after verifying treatment was taken as intended

‡ PBS status as at October 2016: Montelukast is not subsidised by the PBS for children aged 2–5 years with moderate-to-severe asthma, or when used in combination with another preventer.

Asset ID: 25